tobramycin has been researched along with Colonic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bähre, H; Felgner, S; Häussler, S; Müsken, M; Pawar, V; Schwebs, T; Weiss, S | 1 |
Levin, MJ; Mayer, RJ; Siber, GR | 1 |
2 other study(ies) available for tobramycin and Colonic Neoplasms
Article | Year |
---|---|
Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
Topics: Animals; Anti-Bacterial Agents; Biofilms; Colistin; Colonic Neoplasms; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2018 |
Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma.
Topics: Colonic Neoplasms; Feces; Fluorouracil; Humans; Intestinal Absorption; Povidone; Time Factors; Tobramycin | 1980 |